ED vs STRO
Consolidated Edison Inc (ED) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ED and STRO stock pages for the full models.
Not investment advice.